ARCHIVES

Trimodality Therapy Improves Survival In Early Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Test Of HHS Secretary’s Remarks On cancer Mortality Rate Findings

November 22, 1996

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005